Inbox Robot: Millennium Pharmaceuticals News http://www.inboxrobot.com/news/millennium-pharmaceuticals Constantly updated news and information about a variety of topics. Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO http://www.inboxrobot.com/news.php?fid=207090555 8 Jan 2009 12:58 GMT ... Pharmaceuticals Corporation (ASPV, acquired by Galenica group, SWX: ), Cor Therapeutics (CORR; acquired by Millennium Pharmaceuticals, MLNM), Corixa (CRXA; acquired by GlaxoSmithKline, GSK), Coulter Pharmaceutical (CLTR; acquired by Corixa Pharmaceuticals, CRXA), ... Crucell confirms talks for potential Wyeth deal http://www.inboxrobot.com/news.php?fid=206977112 7 Jan 2009 22:30 GMT ... of cancer drug developer Kosan Biosciences Inc. and Japan-based Takeda's $8.8 billion buyout of Millennium Pharmaceuticals. ... Wyeth, vaccine maker Crucell in acquisition talks http://www.inboxrobot.com/news.php?fid=206973367 7 Jan 2009 22:20 GMT ... of cancer drug developer Kosan Biosciences Inc. and Japan-based Takeda's $8.8 billion buyout of Millennium Pharmaceuticals. (C) 2009 The Associated Press. All rights reserved. This material may not be published, ... Celgene shares drop as Baird issues downgrade http://www.inboxrobot.com/news.php?fid=206787073 7 Jan 2009 00:16 GMT ... concern, Raymond said, is that front-line use of the drug is decreasing while competitor Millennium Pharmaceuticals' Velcade gains ground. Other issues include the drug's duration of use in patients, which ... Celgene shares slip as Baird issues downgrade http://www.inboxrobot.com/news.php?fid=206714475 6 Jan 2009 16:55 GMT ... concern, Raymond said, is that front-line use of the drug is decreasing while competitor Millennium Pharmaceuticals' Velcade gains ground. Other issues include the drug's duration of use in patients, which ... Celgene shares fall as Robert W. Baird downgrades shares to 'Neutral' on Revlimid concerns http://www.inboxrobot.com/news.php?fid=206711233 6 Jan 2009 16:34 GMT ... concern, Raymond said, is that front-line use of the drug is decreasing while competitor Millennium Pharmaceuticals' Velcade gains ground. Other issues include the drug's duration of use in patients, which ... Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics http://www.inboxrobot.com/news.php?fid=206693645 6 Jan 2009 15:16 GMT ... ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis. CONTACT: Jules Abraham Lippert Heilshorn & Associates ... Focus on the World Drug Discovery Technologies Market http://www.inboxrobot.com/news.php?fid=206681289 6 Jan 2009 13:51 GMT ... Incyte Genomics, Inc.), Infinity Pharmaceuticals, Inc., Invitrogen Corporation, Medarex, Inc., Merck & Co., Inc., Millennium Pharmaceuticals, Inc., National Center for Drug Screening, PerkinElmer, Inc., Pharmacopeia Inc., Proteome Systems, Quantum Pharmaceuticals, ...